{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T14:17:24Z","timestamp":1766067444727},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,2]]},"DOI":"10.7759\/cureus.19211","type":"journal-article","created":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T17:39:17Z","timestamp":1635874757000},"source":"Crossref","is-referenced-by-count":4,"title":["Relationship of Homocysteine With Gender, Blood Pressure, Body Mass Index, Hemoglobin A1c, and the Duration of Diabetes Mellitus Type 2"],"prefix":"10.7759","author":[{"given":"Aqil","family":"Noor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahboob Ur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noor","family":"Faraz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kashif  A","family":"Samin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amjad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-S081","article-title":"Diagnosis and classification of diabetes mellitus","volume":"37 Suppl 1","author":"American Diabetes Association","year":"2014","unstructured":"American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014, 37 Suppl 1:S81-90. 10.2337\/dc14-S081","journal-title":"Diabetes Care"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.5.1047","article-title":"Global prevalence of diabetes: estimates for the year 2000 and projections for 2030","volume":"27","author":"Wild S","year":"2004","unstructured":"Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004, 27:1047-53. 10.2337\/diacare.27.5.1047","journal-title":"Diabetes Care"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.591792","article-title":"Cardiovascular disease in the developing world and its cost-effective management","volume":"112","author":"Gaziano TA","year":"2005","unstructured":"Gaziano TA. Cardiovascular disease in the developing world and its cost-effective management. Circulation. 2005, 112:3547-53. 10.1161\/CIRCULATIONAHA.105.591792","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v3.i6.110","article-title":"Trends in prevalence of diabetes in Asian countries","volume":"3","author":"Ramachandran A","year":"2012","unstructured":"Ramachandran A, Snehalatha C, Shetty AS, Nanditha A. Trends in prevalence of diabetes in Asian countries. World J Diabetes. 2012, 3:110-7. 10.4239\/wjd.v3.i6.110","journal-title":"World J Diabetes"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.5923\/j.diabetes.20150401.02","article-title":"Type 2 diabetes: challenges to health care system of Pakistan","volume":"4","author":"Ansari RM","year":"2015","unstructured":"Ansari RM, Dixon JB, Coles J. Type 2 diabetes: challenges to health care system of Pakistan. Int J Diabetes Res. 2015, 4:7-12. 10.5923\/j.diabetes.20150401.02","journal-title":"Int J Diabetes Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2013.11.011","article-title":"Diabetes in South-East Asia: an update","volume":"103","author":"Ramachandran A","year":"2014","unstructured":"Ramachandran A, Snehalatha C, Ma RC. Diabetes in South-East Asia: an update. Diabetes Res Clin Pract. 2014, 103:231-7. 10.1016\/j.diabres.2013.11.011","journal-title":"Diabetes Res Clin Pract"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2018.10.006","article-title":"Peripheral neuropathy","volume":"103","author":"Barrell K","year":"2019","unstructured":"Barrell K, Smith AG. Peripheral neuropathy. Med Clin North Am. 2019, 103:383-97. 10.1016\/j.mcna.2018.10.006","journal-title":"Med Clin North Am"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5000279","article-title":"Testing the homocysteine hypothesis in end-stage renal disease: problems and a possible solution","volume":"69","author":"Hoffer LJ","year":"2006","unstructured":"Hoffer LJ. Testing the homocysteine hypothesis in end-stage renal disease: problems and a possible solution. Kidney Int. 2006, 69:1507-10. 10.1038\/sj.ki.5000279","journal-title":"Kidney Int"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-009-9340-0","article-title":"Plasma homocysteine is adversely associated with glomerular filtration rate in asymptomatic black and white young adults: the Bogalusa heart study","volume":"24","author":"Ruan L","year":"2009","unstructured":"Ruan L, Chen W, Srinivasan SR, Xu J, Toprak A, Berenson GS. Plasma homocysteine is adversely associated with glomerular filtration rate in asymptomatic black and white young adults: the Bogalusa heart study. Eur J Epidemiol. 2009, 24:315-9. 10.1007\/s10654-009-9340-0","journal-title":"Eur J Epidemiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112442","article-title":"Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine","volume":"77","author":"Starkebaum G","year":"1986","unstructured":"Starkebaum G, Harlan JM. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest. 1986, 77:1370-6. 10.1172\/JCI112442","journal-title":"J Clin Invest"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116187","article-title":"Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen","volume":"91","author":"Stamler JS","year":"1993","unstructured":"Stamler JS, Osborne JA, Jaraki O, Rabbani LE, Mullins M, Singel D, Loscalzo J. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest. 1993, 91:308-18. 10.1172\/JCI116187","journal-title":"J Clin Invest"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-5491.2001.00445.x","article-title":"Relation between homocysteinaemia and diabetic neuropathy in patients with type 2 diabetes mellitus","volume":"18","author":"Ambrosch A","year":"2001","unstructured":"Ambrosch A, Dierkes J, Lobmann R, K\u00fchne W, K\u00f6nig W, Luley C, Lehnert H. Relation between homocysteinaemia and diabetic neuropathy in patients with type 2 diabetes mellitus. Diabet Med. 2001, 18:185-92. 10.1046\/j.1464-5491.2001.00445.x","journal-title":"Diabet Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S1566-0702(00)00262-9","article-title":"Increasing homocysteine levels and diabetic autonomic neuropathy","volume":"87","author":"Cohen JA","year":"2001","unstructured":"Cohen JA, Jeffers BW, Stabler S, Schrier RW, Estascio R. Increasing homocysteine levels and diabetic autonomic neuropathy. Auton Neurosci. 2001, 87:268-73. 10.1016\/S1566-0702(00)00262-9","journal-title":"Auton Neurosci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2003.12.003","article-title":"Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2","volume":"19","author":"de Luis DA","year":"2005","unstructured":"de Luis DA, Fernandez N, Arranz ML, Aller R, Izaola O, Romero E. Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2. J Diabetes Complications. 2005, 19:42-6. 10.1016\/j.jdiacomp.2003.12.003","journal-title":"J Diabetes Complications"},{"key":"ref15","article-title":"Plasma homocysteine and microvascular complications in type 1 diabetes","volume":"10","author":"Vaccaro O","year":"2000","unstructured":"Vaccaro O, Perna A, Mancini F, et al.. Plasma homocysteine and microvascular complications in type 1 diabetes. Nutr Metab Cardiovasc Dis. 2000, 10:297-304.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2007.1750","article-title":"Vascular oxidant stress and inflammation in hyperhomocysteinemia","volume":"9","author":"Papatheodorou L","year":"2007","unstructured":"Papatheodorou L, Weiss N. Vascular oxidant stress and inflammation in hyperhomocysteinemia. Antioxid Redox Signal. 2007, 9:1941-58. 10.1089\/ars.2007.1750","journal-title":"Antioxid Redox Signal"},{"key":"ref17","article-title":"Plasma homocysteine level in patients with diabetes mellitus","volume":"16","author":"Shaikh MK","year":"2012","unstructured":"Shaikh MK, Devrajani BR, Shaikh A, Shah SZ, Shaikh S, Singh D. Plasma homocysteine level in patients with diabetes mellitus. World Appl Sci J. 2012, 16:1269-73.","journal-title":"World Appl Sci J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.101.13.1506","article-title":"Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes: 5-year follow-up of the Hoorn Study","volume":"101","author":"Hoogeveen EK","year":"2000","unstructured":"Hoogeveen EK, Kostense PJ, Jakobs C, et al.. Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes: 5-year follow-up of the Hoorn Study. Circulation. 2000, 101:1506-11. 10.1161\/01.cir.101.13.1506","journal-title":"Circulation"},{"key":"ref19","article-title":"Evaluation of the level of plasma homocysteine in patients with type 2 diabetes mellitus under metformin treatment and its correlation with serum total antioxidant capacity, malondialdehyde, creatinine, insulin resistance and glycemic control","volume":"19","author":"Aghamohammadi V","year":"2011","unstructured":"Aghamohammadi V, PourghassemGargari B, Aliasgharzadeh A. Evaluation of the level of plasma homocysteine in patients with type 2 diabetes mellitus under metformin treatment and its correlation with serum total antioxidant capacity, malondialdehyde, creatinine, insulin resistance and glycemic control. J Adv Med Biomed Res. 2011, 19:1-10.","journal-title":"J Adv Med Biomed Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.5.1637","article-title":"Improved insulin sensitivity and metabolic control in type 2 diabetes does not influence plasma homocysteine","volume":"26","author":"Pouwels MJ","year":"2003","unstructured":"Pouwels MJ, Den Heijer M, Blom HJ, Tack CJ, Hermus AR. Improved insulin sensitivity and metabolic control in type 2 diabetes does not influence plasma homocysteine. Diabetes Care. 2003, 26:1637-9. 10.2337\/diacare.26.5.1637","journal-title":"Diabetes Care"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v5.i4.444","article-title":"Type 2 diabetes and cardiovascular disease: have all risk factors the same strength?","volume":"5","author":"Mart\u00edn-Tim\u00f3n I","year":"2014","unstructured":"Mart\u00edn-Tim\u00f3n I, Sevillano-Collantes C, Segura-Galindo A, Del Ca\u00f1izo-G\u00f3mez FJ. Type 2 diabetes and cardiovascular disease: have all risk factors the same strength?. World J Diabetes. 2014, 5:444-70. 10.4239\/wjd.v5.i4.444","journal-title":"World J Diabetes"},{"key":"ref22","article-title":"Homocysteine concentrations in type 2 diabetes mellitus patients without cardiovascular disease: relationship to metabolic parameters and diabetic complications","volume":"1","author":"Tarkun I","year":"2003","unstructured":"Tarkun I, Arslan B, Cant\u00fcrk Z, Tarkun P, Kozda\u011f G, Topsever P. Homocysteine concentrations in type 2 diabetes mellitus patients without cardiovascular disease: relationship to metabolic parameters and diabetic complications. Turk J Endocrinol Metab. 2003, 1:11-7.","journal-title":"Turk J Endocrinol Metab"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2796.2003.01184.x","article-title":"Effect of metabolic control on homocysteine levels in type 2 diabetic patients: a 3-year follow-up","volume":"254","author":"Passaro A","year":"2003","unstructured":"Passaro A, Calzoni F, Volpato S, et al.. Effect of metabolic control on homocysteine levels in type 2 diabetic patients: a 3-year follow-up. J Intern Med. 2003, 254:264-71. 10.1046\/j.1365-2796.2003.01184.x","journal-title":"J Intern Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s13410-013-0154-y","article-title":"Plasma homocysteine level and its clinical correlation with type 2 diabetes mellitus and its complications","volume":"34","author":"Sonkar SK","year":"2014","unstructured":"Sonkar SK, Sonkar GK, Soni D, Soni D, Usman K. Plasma homocysteine level and its clinical correlation with type 2 diabetes mellitus and its complications. Int J Diabetes Dev Ctries. 2014, 34:3-6. 10.1007\/s13410-013-0154-y","journal-title":"Int J Diabetes Dev Ctries"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2005.10.025","article-title":"Homocysteine and other biochemical parameters in type 2 diabetes mellitus with different diabetic duration or diabetic retinopathy","volume":"366","author":"Huang EJ","year":"2006","unstructured":"Huang EJ, Kuo WW, Chen YJ, et al.. Homocysteine and other biochemical parameters in type 2 diabetes mellitus with different diabetic duration or diabetic retinopathy. Clin Chim Acta. 2006, 366:293-8. 10.1016\/j.cca.2005.10.025","journal-title":"Clin Chim Acta"},{"key":"ref26","article-title":"Study of assessment of plasma homocysteine level in microvascular complications of type 2 diabetes mellitus","volume":"4","author":"Mundu PA","year":"2017","unstructured":"Mundu PA, Kumar B, Mitra JK, Kumar M, Sinha R. Study of assessment of plasma homocysteine level in microvascular complications of type 2 diabetes mellitus. Int J Contemporary Med Res. 2017, 4:879-83.","journal-title":"Int J Contemporary Med Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/68967-relationship-of-homocysteine-with-gender-blood-pressure-body-mass-index-hemoglobin-a1c-and-the-duration-of-diabetes-mellitus-type-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:36:10Z","timestamp":1707507370000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/68967-relationship-of-homocysteine-with-gender-blood-pressure-body-mass-index-hemoglobin-a1c-and-the-duration-of-diabetes-mellitus-type-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,2]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.19211","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,2]]}}}